Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Parenteral formulations of rasagiline

Parenteral formulations of rasagiline

US Patent 9308182 · Granted Apr 12, 2016

Estimated economic value: $291,171,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of rasagiline for the treatment of restless legs syndrome2025
Methods and compositions with immune therapy for treatment of dementia2018
Methods of manufacturing viscous liquid pharmaceutical formulations2017
Use of laquinimod for treating Crohn's disease patients who failed first-line an2015
Use of rasagilline for the treatment of restless legs syndrome2015
Treatment of Crohn's disease with laquinimod2013
Treatment of rheumatoid arthritis with a combination of laquinimod and methotrex2013
Particle formulations for use in pharmaceutical compositions2013
Pulmonary surfactant formulations2012
Composition and dosage form comprising a particle formulation and suspending veh2012
Composition and dosage form comprising a particle formulation and suspending veh2011
Tumor associated antigen peptides and use of same as anti-tumor vaccines2011